Summary: GLP-1 receptor agonists do not directly cause sweating, but some patients report changes in perspiration patterns due to indirect factors such as gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or autonomic responses to nausea
Available in Sweet Grape Candy and Green Apple Candy designed to taste like a candy treat, not a supplement
Signs that insulin may be needed include persistently elevated blood sugar despite maximum GLP-1 doses, declining endogenous insulin production, and treatment plateaus that suggest the incretin-based approach has reached its limits
Author contributions HM and AS conceived the project and wrote the manuscript
Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1
Examorelin is an alternative name for Hexarelin used in scientific literature and refers to the same peptide compound identified by CAS 140703-51-1